AiTA Bio Inc. Announces Strategic Additions to Its Board of Directors and Advisory Board
NEW YORK, Dec. 7, 2023 /PRNewswire/ -- AiTA Bio, a pioneering bio-MEMS company based in New York City revolutionizing the healthcare technology landscape, is excited to announce the appointment of four industry leading veterans to its board of directors and advisory team, underscoring the company's commitment to continued innovation and operational excellence in advancing its groundbreaking augmented biology platform.
New Board Member:
New Strategic Advisors:
Jacob Menture and Dilan Casanovas, Founders of AiTA Bio, commented:
"We are thrilled to welcome Rich, Martin, Mark, and David to the AiTA Bio team. Their world-class expertise in global supply chain management, commercialization, and strategic business development aligns perfectly with the needs of the business as we position ourselves for high-volume production. We are confident that their distinguished industry track records, commercial marketplace successes, and strategic insights will greatly contribute to our mission of enhancing drug delivery systems and improving patient outcomes."
About AiTA Bio Inc.
AiTA Bio Inc. is a bio-MEMS technology company focused on developing an intelligent sensing and delivery, next-generation drug delivery platform. The company has leveraged its drug delivery chip technology to develop the first all-in-one insulin pump and continuous glucose monitoring product for the treatment of Type 1 Diabetes Mellitus.
AiTA Bio is Headquartered in New York City
Locations: New York City & San Diego
For Media Contact:
For Investors Contact:
SOURCE AiTA Bio Inc.